Tactile Systems Technology, Inc. Selling and Marketing Expense
Tactile Systems Technology, Inc. (TCMD) reported Selling and Marketing Expense of $32.01 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-10
- Tactile Systems Technology, Inc. selling and marketing expense for the quarter ending 2026-06-30 was $32.01M, a 6.57% increase year-over-year.
- Tactile Systems Technology, Inc. selling and marketing expense for the quarter ending 2026-03-31 was $32.73M, a 18.96% increase year-over-year.
- Tactile Systems Technology, Inc. selling and marketing expense for the quarter ending 2025-12-31 was $33.87M, a 15.98% increase year-over-year.
- Tactile Systems Technology, Inc. selling and marketing expense for the quarter ending 2025-09-30 was $29.81M, a 11.07% increase year-over-year.
- Tactile Systems Technology, Inc. selling and marketing expense for fiscal 2025 was $121.24M, a 8.24% increase from fiscal 2024.
- Tactile Systems Technology, Inc. selling and marketing expense for fiscal 2024 was $112.01M, a 4.57% increase from fiscal 2023.
- Tactile Systems Technology, Inc. selling and marketing expense for fiscal 2023 was $107.12M, a 0.66% increase from fiscal 2022.
- Tactile Systems Technology, Inc. selling and marketing expense for fiscal 2022 was $106.42M, a 22.64% increase from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $32.01M 10-Q · filed 2026-08-10 | $64.74M 10-Q · filed 2026-08-10 | $98.62M derived: sum of 3 quarters · filed 2026-08-10 | $128.43M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $32.73M 10-Q · filed 2026-05-04 | $66.61M derived: sum of 2 quarters · filed 2026-05-04 | $96.41M derived: sum of 3 quarters · filed 2026-05-04 | $126.45M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $33.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $63.68M derived: sum of 2 quarters · filed 2026-02-17 | $93.72M derived: sum of 3 quarters · filed 2026-08-10 | $121.24M 10-K · filed 2026-02-17 |
| 2025-09-30 | $29.81M 10-Q · filed 2025-11-03 | $59.85M derived: sum of 2 quarters · filed 2026-08-10 | $87.36M 10-Q · filed 2025-11-03 | $116.57M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $30.04M 10-Q · filed 2026-08-10 | $57.55M 10-Q · filed 2026-08-10 | $86.76M derived: sum of 3 quarters · filed 2026-08-10 | $113.60M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $27.52M 10-Q · filed 2026-05-04 | $56.72M derived: sum of 2 quarters · filed 2026-05-04 | $83.56M derived: sum of 3 quarters · filed 2026-05-04 | $112.17M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $29.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $56.04M derived: sum of 2 quarters · filed 2026-02-17 | $84.65M derived: sum of 3 quarters · filed 2026-02-17 | $112.01M 10-K · filed 2026-02-17 |
| 2024-09-30 | $26.84M 10-Q · filed 2025-11-03 | $55.45M derived: sum of 2 quarters · filed 2025-11-03 | $82.80M 10-Q · filed 2025-11-03 | $109.38M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $28.61M 10-Q · filed 2025-08-04 | $55.97M 10-Q · filed 2025-08-04 | $82.55M derived: sum of 3 quarters · filed 2026-02-17 | $108.58M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $27.36M 10-Q · filed 2025-05-05 | $53.94M derived: sum of 2 quarters · filed 2026-02-17 | $79.97M derived: sum of 3 quarters · filed 2026-02-17 | $108.17M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $26.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $52.61M derived: sum of 2 quarters · filed 2026-02-17 | $80.82M derived: sum of 3 quarters · filed 2026-02-17 | $107.12M 10-K · filed 2026-02-17 |
| 2023-09-30 | $26.03M 10-Q · filed 2024-11-04 | $54.24M derived: sum of 2 quarters · filed 2024-11-04 | $80.54M 10-Q · filed 2024-11-04 | $107.62M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $28.21M 10-Q · filed 2024-08-05 | $54.51M 10-Q · filed 2024-08-05 | $81.59M derived: sum of 3 quarters · filed 2025-02-18 | $108.17M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $26.30M 10-Q · filed 2024-05-06 | $53.38M derived: sum of 2 quarters · filed 2025-02-18 | $79.97M derived: sum of 3 quarters · filed 2025-02-18 | $108.79M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $27.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $53.67M derived: sum of 2 quarters · filed 2025-02-18 | $82.49M derived: sum of 3 quarters · filed 2025-02-18 | $106.42M 10-K · filed 2025-02-18 |
| 2022-09-30 | $26.58M 10-Q · filed 2023-11-06 | $55.41M derived: sum of 2 quarters · filed 2023-11-06 | $79.33M 10-Q · filed 2023-11-06 | $104.16M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $28.82M 10-Q · filed 2023-08-07 | $52.75M 10-Q · filed 2023-08-07 | $77.58M derived: sum of 3 quarters · filed 2024-02-20 | $99.81M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $23.93M 10-Q · filed 2023-05-08 | $48.76M derived: sum of 2 quarters · filed 2024-02-20 | $70.99M derived: sum of 3 quarters · filed 2024-02-20 | $91.92M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $24.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $47.06M derived: sum of 2 quarters · filed 2024-02-20 | $67.99M derived: sum of 3 quarters · filed 2024-02-20 | $86.78M 10-K · filed 2024-02-20 |
| 2021-09-30 | $22.23M 10-Q · filed 2022-11-07 | $43.16M derived: sum of 2 quarters · filed 2022-11-07 | $61.95M 10-Q · filed 2022-11-07 | $81.73M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $20.93M 10-Q · filed 2022-08-01 | $39.72M 10-Q · filed 2022-08-01 | $59.50M derived: sum of 3 quarters · filed 2023-02-21 | $78.98M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $18.79M 10-Q · filed 2022-05-02 | $38.56M derived: sum of 2 quarters · filed 2023-02-21 | $58.05M derived: sum of 3 quarters · filed 2023-02-21 | $75.45M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $19.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $39.27M derived: sum of 2 quarters · filed 2023-02-21 | $56.66M derived: sum of 3 quarters · filed 2023-02-21 | $79.63M 10-K · filed 2023-02-21 |
| 2020-09-30 | $19.49M 10-Q · filed 2021-11-08 | $36.89M derived: sum of 2 quarters · filed 2021-11-08 | $59.86M 10-Q · filed 2021-11-08 | $82.23M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $17.40M 10-Q · filed 2021-08-02 | $40.37M 10-Q · filed 2021-08-02 | $62.74M derived: sum of 3 quarters · filed 2022-02-23 | $83.48M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $22.97M 10-Q · filed 2021-05-03 | $45.34M derived: sum of 2 quarters · filed 2022-02-23 | $66.08M derived: sum of 3 quarters · filed 2022-02-23 | $84.50M derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | $22.37M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $43.11M derived: sum of 2 quarters · filed 2022-02-23 | $61.53M derived: sum of 3 quarters · filed 2022-02-23 | $78.92M 10-K · filed 2022-02-23 |
| 2019-09-30 | $20.74M 10-Q · filed 2020-11-02 | $39.16M derived: sum of 2 quarters · filed 2020-11-02 | $56.55M 10-Q · filed 2020-11-02 | $74.28M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $18.42M 10-Q · filed 2020-08-03 | $35.81M 10-Q · filed 2020-08-03 | $53.54M derived: sum of 3 quarters · filed 2021-02-23 | $69.17M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $17.39M 10-Q · filed 2020-05-04 | $35.12M derived: sum of 2 quarters · filed 2021-02-23 | $50.75M derived: sum of 3 quarters · filed 2021-02-23 | $65.20M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $17.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $33.36M derived: sum of 2 quarters · filed 2021-02-23 | $47.81M derived: sum of 3 quarters · filed 2021-02-23 | $60.37M 10-K · filed 2021-02-23 |
| 2018-09-30 | $15.63M 10-Q · filed 2019-11-04 | $30.08M derived: sum of 2 quarters · filed 2019-11-04 | $42.64M 10-Q · filed 2019-11-04 | $55.31M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $14.45M 10-Q · filed 2019-08-05 | $27.01M 10-Q · filed 2019-08-05 | $39.68M derived: sum of 3 quarters · filed 2020-02-26 | $50.59M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $12.56M 10-Q · filed 2019-05-06 | $25.23M derived: sum of 2 quarters · filed 2020-02-26 | $36.14M derived: sum of 3 quarters · filed 2020-02-26 | $46.79M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $12.67M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $23.59M derived: sum of 2 quarters · filed 2020-02-26 | $34.23M derived: sum of 3 quarters · filed 2020-02-26 | $44.40M 10-K · filed 2020-02-26 |
| 2017-09-30 | $10.91M 10-Q · filed 2018-11-05 | $21.56M derived: sum of 2 quarters · filed 2018-11-05 | $31.73M 10-Q · filed 2018-11-05 | $41.66M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $10.64M 10-Q · filed 2018-08-06 | $20.81M 10-Q · filed 2018-08-06 | $30.75M derived: sum of 3 quarters · filed 2019-02-28 | $39.73M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $10.17M 10-Q · filed 2018-05-07 | $20.10M derived: sum of 2 quarters · filed 2019-02-28 | $29.08M derived: sum of 3 quarters · filed 2019-02-28 | $36.68M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $9.94M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $18.91M derived: sum of 2 quarters · filed 2019-02-28 | $26.51M derived: sum of 3 quarters · filed 2019-02-28 | $33.79M 10-K · filed 2019-02-28 |
| 2016-09-30 | $8.98M 10-Q · filed 2017-11-07 | $16.58M derived: sum of 2 quarters · filed 2017-11-07 | $23.86M 10-Q · filed 2017-11-07 | $31.05M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $7.60M 10-Q · filed 2017-08-07 | $14.88M 10-Q · filed 2017-08-07 | $22.07M derived: sum of 3 quarters · filed 2018-02-26 | $28.27M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $7.28M 10-Q · filed 2017-05-08 | $14.47M derived: sum of 2 quarters · filed 2018-02-26 | $20.67M derived: sum of 3 quarters · filed 2018-02-26 | $26.60M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $7.19M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $13.39M derived: sum of 2 quarters · filed 2018-02-26 | $19.32M derived: sum of 3 quarters · filed 2018-02-26 | $24.48M 10-K · filed 2018-02-26 |
| 2015-09-30 | $6.20M 10-Q · filed 2016-11-10 | $12.13M derived: sum of 2 quarters · filed 2016-11-10 | $17.30M 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $5.93M 10-Q · filed 2016-09-07 | $11.10M 10-Q · filed 2016-09-07 | ||
| 2014-12-31 | $18.15M 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |